| Authors: |
Hong MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul., Park S; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Vo T; Merck & Co., Inc., Rahway, USA., Cho J; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul., Jung HA; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Kim SH; Department of Otorhinolaryngology., Zhou H; Merck & Co., Inc., Rahway, USA., Chirovsky D; Merck & Co., Inc., Rahway, USA., Koh YW; Department of Otorhinolaryngology., Yoon SO; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea., Webber AL; Merck & Co., Inc., Rahway, USA., Gumuscu B; Merck & Co., Inc., Rahway, USA., Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul. Electronic address: CBC1971@yuhs.ac., Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: silkahn@skku.edu. |
